Siemens Healthcare has received FDA clearance for their MAMMOMAT Inspiration Prime Edition lower dose mammography system.
Siemens Healthcare has received FDA clearance for their MAMMOMAT Inspiration Prime Edition mammography system, which lowers radiation dose by up to 30 percent, the company said.
This latest MAMMOMAT system reduces dose by replacing the standard scatter radiation grid with a new algorithm for progressive image reconstruction, according to Siemens. The algorithm can identify scatter-causing structures and calculating a corrected image. This may enable the complete use of primary radiation to achieve lower dose, the company said.
The design of the MAMMOMAT Inspiration Prime Edition obviates the need for a grid, the company said, and lower doses compared to the predecessor model are needed for high-quality images. This edition is based the MAMMOMAT Inspiration platform which has been used since 2007.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.